Terms: = Breast cancer AND NOTCH2, Q04721, 4853, ENSG00000134250, AGS2, hN2 AND Treatment
30 results:
1. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract] [Full Text] [Related]
2.
Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
[TBL] [Abstract] [Full Text] [Related]
3. Solid-Basaloid Adenoid Cystic Carcinoma of the breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
[TBL] [Abstract] [Full Text] [Related]
4. Trastuzumab-induced human cardiomyocyte damage through the notch2/JAK2/STAT3 pathway.
Su Z; Liu S; Zou Y; Shan L; Yu M; Xie S; Li X; Jin Y
Clinics (Sao Paulo); 2023; 78():100268. PubMed ID: 37567042
[TBL] [Abstract] [Full Text] [Related]
5. Genomics of
Lipsyc-Sharf M; Jain E; Collins LC; Rosenberg SM; Ruddy KJ; Tamimi RM; Schapira L; Come SE; Peppercorn JM; Borges VF; Warner E; Snow C; Krop IE; Kim D; Weiss J; Zanudo JGT; Partridge AH; Wagle N; Waks AG
JCO Precis Oncol; 2023 Jun; 7():e2300076. PubMed ID: 37364233
[TBL] [Abstract] [Full Text] [Related]
6. Selenite Inhibits Notch Signaling in Cells and Mice.
Powers M; Liu L; Deemer D; Chen S; Scholl A; Yoshinaga M; Liu Z
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802299
[TBL] [Abstract] [Full Text] [Related]
7. Association between tumor mutation profile and clinical outcomes among Hispanic Latina women with triple-negative breast cancer.
Philipovskiy A; Dwivedi AK; Gamez R; McCallum R; Mukherjee D; Nahleh Z; Aguilera RJ; Gaur S
PLoS One; 2020; 15(9):e0238262. PubMed ID: 32886682
[TBL] [Abstract] [Full Text] [Related]
8. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway.
Jiang H; Li X; Wang W; Dong H
BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233
[TBL] [Abstract] [Full Text] [Related]
9. breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study.
McCormack V; McKenzie F; Foerster M; Zietsman A; Galukande M; Adisa C; Anele A; Parham G; Pinder LF; Cubasch H; Joffe M; Beaney T; Quaresma M; Togawa K; Abedi-Ardekani B; Anderson BO; Schüz J; Dos-Santos-Silva I
Lancet Glob Health; 2020 Sep; 8(9):e1203-e1212. PubMed ID: 32827482
[TBL] [Abstract] [Full Text] [Related]
10. Cholesterol and Mevalonate: Two Metabolites Involved in breast cancer Progression and Drug Resistance through the ERRα Pathway.
Brindisi M; Fiorillo M; Frattaruolo L; Sotgia F; Lisanti MP; Cappello AR
Cells; 2020 Jul; 9(8):. PubMed ID: 32751976
[TBL] [Abstract] [Full Text] [Related]
11. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells.
Xu Z; Liu C; Zhao Q; Lü J; Ding X; Luo A; He J; Wang G; Li Y; Cai Z; Wang Z; Liu J; Liu S; Li W; Yu Z
Pharmacol Res; 2020 Feb; 152():104628. PubMed ID: 31904506
[TBL] [Abstract] [Full Text] [Related]
12. Notch signaling pathway regulates CD4
Yang L; Zhao KL; Qin L; Ji DX; Zhang B; Zheng PF; Qin YM
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988066
[TBL] [Abstract] [Full Text] [Related]
13. Identifying Circulating Tumor DNA Mutation Profiles in Metastatic breast cancer Patients with Multiline Resistance.
Hu ZY; Xie N; Tian C; Yang X; Liu L; Li J; Xiao H; Wu H; Lu J; Gao J; Hu X; Cao M; Shui Z; Xiao M; Tang Y; He Q; Chang L; Xia X; Yi X; Liao Q; Ouyang Q
EBioMedicine; 2018 Jun; 32():111-118. PubMed ID: 29807833
[TBL] [Abstract] [Full Text] [Related]
14. Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancer.
Shan NL; Wahler J; Lee HJ; Bak MJ; Gupta SD; Maehr H; Suh N
J Steroid Biochem Mol Biol; 2017 Oct; 173():122-129. PubMed ID: 27923595
[TBL] [Abstract] [Full Text] [Related]
15. Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk.
Thounaojam MC; Dudimah DF; Pellom ST; Uzhachenko RV; Carbone DP; Dikov MM; Shanker A
Oncotarget; 2015 Oct; 6(32):32439-55. PubMed ID: 26431276
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic values of Notch receptors in breast cancer.
Xu J; Song F; Jin T; Qin J; Wu J; Wang M; Wang Y; Liu J
Tumour Biol; 2016 Feb; 37(2):1871-7. PubMed ID: 26323259
[TBL] [Abstract] [Full Text] [Related]
17. Targeting Notch signaling with a notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.
Yen WC; Fischer MM; Axelrod F; Bond C; Cain J; Cancilla B; Henner WR; Meisner R; Sato A; Shah J; Tang T; Wallace B; Wang M; Zhang C; Kapoun AM; Lewicki J; Gurney A; Hoey T
Clin Cancer Res; 2015 May; 21(9):2084-95. PubMed ID: 25934888
[TBL] [Abstract] [Full Text] [Related]
18. Novel anticancer activity of phloroglucinol against breast cancer stem-like cells.
Kim RK; Uddin N; Hyun JW; Kim C; Suh Y; Lee SJ
Toxicol Appl Pharmacol; 2015 Aug; 286(3):143-50. PubMed ID: 25843036
[TBL] [Abstract] [Full Text] [Related]
19. The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate.
Kim SH; Singh SV
Breast Cancer Res Treat; 2015 Feb; 149(3):681-92. PubMed ID: 25663545
[TBL] [Abstract] [Full Text] [Related]
20. notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells.
Sehrawat A; Sakao K; Singh SV
Breast Cancer Res Treat; 2014 Aug; 146(3):543-55. PubMed ID: 25038880
[TBL] [Abstract] [Full Text] [Related]
[Next]